In its quarterly report, Pfizer reported that it is projecting $54 billion in revenue in 2022 from the covid vaccine and treatment pills.
The CEO also mentioned that the supply of the covid antivirals would be more widely distributed in the coming months.
On the announcement, the stock dropped slightly. I’m guessing that the projection was already baked into the stock price and Fauci’s announcement of covid pandemic phase nearing an end might have played a part as well. The non-covid items at Pfizer did worse than expected.
Did you know that the UK pays the highest price for the vaccine than any other country and that the contract with Pfizer is secret?
There are suggestions that the delay experienced by the Oxford Astrazeneca vaccine after a dubious to say the least safety concern in the US was to allow Pfizer to catch up.
Covid has/is a nice earner for Pfizer and its shareholders.
The British government is reportedly set to announce the $1.4 billion deal this week, a per dose price of $40.
The UK has grown increasingly concerned about its vaccine supply since the EU secured an additional 900 million Pfizer/BioNTech doses over the next two years.
That’ll be BJ - spending other people’s money again …
Even if that were true, I don’t think Pfizer was recommending it to pregnant women. Their study for pregnant women got delayed due to lack of enrollment, and their original study didn’t include them.
The groups recommending vaccines to pregnant women were from the government, not the company. And the government groups didn’t initially recommend them for every pregnant woman, only those who had consulted with their physician.
